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Abstract: By providing useful tools to study host–pathogen interactions, next-generation omics
has recently enabled the study of gene expression changes in both pathogen and infected host
simultaneously. However, since great discriminative power is required to study pathogen and
host simultaneously throughout the infection process, the depth of quantitative gene expression
profiling has proven to be unsatisfactory when focusing on bacterial pathogens, thus preferentially
requiring specific strategies or the development of novel methodologies based on complementary
omics approaches. In this review, we focus on the difficulties encountered when making use of
proteogenomics approaches to study bacterial pathogenesis. In addition, we review different omics
strategies (i.e., transcriptomics, proteomics and secretomics) and their applications for studying
interactions of pathogens with their host.
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1. General Introduction
Over the years, efforts have been made to classify microorganisms as either pathogenic or
non-pathogenic, and to understand the virulence of the former. At the very beginning, virulence was
thought to be an intrinsic capacity of only certain microorganisms [1]. While such a strict division
is embodied in Koch postulates [2], widely used in medical microbiology since 1880, advances in
the research field of infectious diseases led to a progressive flexibility of the threshold to classify
a microorganism as pathogenic or not (reviewed by Pierre-Olivier Méthot and co-workers [1]).
Accumulating evidence suggests the involvement of host innate and adaptive immune responses and
environmental conditions as key factors in determining a pathogen’s ability to infect a host. Altogether
this brings us to the current definition of virulence as ‘the outcome of a host–pathogen interaction’,
thus not considering intrinsic properties of the microbe or host separately [3]. Despite significant
efforts and the knowledge gained when studying microorganisms as separate entities, one of the
remaining challenges of the host–pathogen interaction research field is to understand the behavior of
pathogens in the context of their hosts and vice versa. Overall, this stresses the need for integrative
studies of host–pathogen interactions.
More specifically, unravelling host–pathogen interactions is of central importance to understand
the host response to infection and the mechanisms employed by microorganisms to subvert host
defenses, and for the discovery of novel antimicrobial targets. Omics approaches have the advantage
of enabling integrative studies of system alterations at different levels, including transcription, protein
synthesis and alterations of the proteome amongst others. Therefore, the applications of omics-based
strategies are key for the discovery of mechanisms steering bacterial virulence and pathogenesis.
In this article, we focus on proteogenomics approaches, an area of research at the intersection of
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genomics, transcriptomics and proteomics. However, despite major advancements, proteogenomics
approaches still have significant limitations when applied to study pathogens in the context of the
host—a shortcoming that is mainly due to the macromolecular content of eukaryotic cells differing
by several orders of magnitude from that of prokaryotes, making such studies extremely challenging.
Furthermore, the lengthy procedures frequently applied to enrich for bacteria might influence the data
outcome. Another limitation comes from the fact that reproduction and interpretation of reported
findings is often complicated or even precluded due to the scarcity of details provided regarding the
experimental setups used (Table S1). Moreover, the high variability of the infection capacity of the
pathogen and the overall infection efficiency also contribute to the observed high variability in infected
cell (sub-) populations. Thus, ideally, host–pathogen interactions are studied on the single cell level;
however, such studies are not yet routinely performed. In this review, we focus on the application of
various omics approaches that permit the study of host–pathogen interactions using bacterial pathogens
as infective agents and specifically focus on studies enabling detection of proteogenomics changes in
the bacterial pathogen within infected cells while not focusing on studies reporting host cell changes,
since omics analysis of the latter can essentially be performed using routine procedures. For proteomic
tools enabling the study of bacterial pathogen protein/host protein interactions, we would like to refer
the reader to a recent review discussing such studies in more detail [4].
2. Current Limitations for the Application of Omics in Host–Pathogen Interaction Studies
When applying omics approaches for studying host–pathogen interactions, it is important to
consider the differences concerning the host and pathogen molecular contents (Figure 1). If the focus
is on the host, studies can largely neglect the pathogen content [5–7]. Nonetheless, if the focus is on
the pathogen’s response, its molecular content becomes limiting, making it highly desirable or even
required to implement strategies to enrich the molecular content of the pathogen, strategies which are,
however, not always available or easy to implement. As such, a frequently used alternative approach
to study pathogenic responses is the in vitro growth of the pathogen in conditions mimicking the host
environment [8–11]. In this context, it is noteworthy that despite the reliable and often ease of use of
in vitro or in cellulo models to study bacterial pathogen interactions with host cells, it has become
apparent that these interaction models have shortcomings in that they do not always accurately reflect
in vivo infection conditions (i.e., in case of infection the lack of an immune response or difference in
physiological conditions [12], bacterial micro colony formation and host cell polarity [13] amongst
others) and therefore are sometimes referred to as being a reductionist approach [14]. To avoid studying
cells in isolation and overcoming some of these shortcomings, in vivo models making use of a broad
variety of animals ranging from invertebrates to non-human primates can be opted for depending
on the bacterial pathogen of study. Sometimes however, no appropriate in vivo models are available
because of the fact that the manifestation of the disease is very different from the corresponding
human disease. In case of the latter, one could turn to the use of so-called ex vivo models that
comprise infection of isolated tissues. For example, blood, saliva and placenta explants can be used
for studying Neisseria meningitidis [15], Streptococcus pyogenes [16], and Listeria monocytogenes [17]
infections, respectively.
To address the differences between the host and bacterial pathogen, one of the first things to
consider is their difference in size. The diameter of eukaryotic cells typically ranges from 10 to 100 µm,
whereas that of bacteria ranges from 0.1 to 2 µm [18]. Consequently, when considering cells as spheres,
their volumes are ~105 to ~109 µm3, for bacteria and eukaryotic cells respectively. In terms of genomic
content, eukaryotes possess larger and more complex genomes than prokaryotes; the genome of
bacterial pathogens varies between 0.8 and 8 Mb, whereas the genome of higher eukaryotic organisms
such as human (Homo sapiens) and mouse (Mus musculus) is about 2996 and 2671 Mb, respectively [19],
thus about several hundred times larger. A bacterial pathogen contains approximatively 5 to 10 times
less genes than their eukaryotic hosts. For example, H. sapiens encodes about 20,457 protein-coding
genes, while Salmonella enterica subsp. enterica serovar Typhimurium (hereinafter referred to as
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S. typhimurium) strain LT2 encodes 4423 protein-coding genes [20]. As such, without considering
all possible proteoforms (e.g., variant of proteins raised upon alternative splicing and alternative
translation initiation amongst others) [21], eukaryotic proteomes are about one order of magnitude
larger than their prokaryotic counterparts in absolute numbers of unique proteins (Figure 1).
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living organisms. Eukaryotic cells and bacteria also have great differences in terms of their 
macromolecule content. Genomes differ in aspects such as size and organization, whereas the RNA 
content is about 20 times higher in eukaryotic cells. Finally, at the protein level, these organisms 
display differences not only in absolute numbers of proteins [20] and proteoforms expressed, but also
in terms of the total amount of protein molecules per cell. 
Moreover, when studying the proteome of an infected host, the mass spectrometry-based 
identification of bacterial proteins is highly challenging given their overall much lower levels and the 
fact that despite recent improvements in accuracy, sensitivity and speed of mass spectrometers and
the performance of liquid chromatography, ionization suppression and an overall low loading
capacity still result in under-sampling [22]. This limits the coverage of complex samples, which can
only be partially overcome by increasing the overall time spent on analyzing samples [23]. A
representative example of how the number of Salmonella proteins identified using liquid
chromatography coupled with tandem mass spectrometry (LC-MS/MS) decreases when analyzing
complex peptide mixtures, being a Salmonella total protein dilution series in lysates of human HeLa 
cells, is shown in Figure 2. Here, the number of identified Salmonella proteins when comparing a pure 
Salmonella versus a 1:999 pathogen/host peptide mixture drops already ~5 fold (i.e., from 1600 to 295 
protein identifications). 
 
 
 
 
 
  
  
 
   
  
 
 
   
    
 
 
 
   
  
Figure 1. Macromolecular differences between cells of eukaryotic and bacterial origin. Eukaryotic
and bacterial cells differ greatly in many aspects. First, in terms of size, these organisms are
considerably different. Eukaryotic cells have a size that ranges between 10 and 100 µm, whereas
bacteria are typically 0.1 to 2 µm of length. Macromolecules are the building blocks of life, present in
all known living organisms. Eukaryotic cells and bacteria also have great differences in terms of their
macromolecule content. Genomes differ in aspects such as size and organization, whereas the RNA
content is about 20 times higher in eukaryotic cells. Finally, at the protein level, these organisms display
differences not only in absolute numbers of proteins [20] and proteoforms expressed, but also in terms
of the total amount of protein molecules per cell.
Moreover, when studying the proteome of a infected host, the mass sp ctrometry-based
identific tion of bacterial proteins is highly hallenging gi en their overall much lower lev ls and the
fact that despite recent improvements in accuracy, sensitivity and speed of mass spectrometers and the
performance of liquid chromatography, ionization suppression and an overall low loading capacity
still result in under-sampling [22]. This limits the coverage of complex samples, which can only be
partially overcome by increasing the overall time spent on analyzing samples [23]. A representative
example of how the number of Salmonella proteins identified using liquid chromatography coupled
with tandem mass spectrometry (LC-MS/MS) decreases when analyzing complex peptide mixtures,
being a Salmonella total protein dilution series in lysates of human HeLa cells, is shown in Figure 2.
Here, the number of identified Salmonella proteins when comparing a pure Salmonella versus a 1:999
pathogen/host peptide mixture drops already ~5 fold (i.e., from 1600 to 295 protein identifications).
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respectively and white indicates that the protein was not identified in the corresponding experimental 
setup analyzed. In the upper part of the figure, the bar chart shows the number of proteins identified 
in every condition. The precise number of Salmonella proteins identified was 1600 (S), 1391 (S:H 1:1), 
1120 (S:H 1:3), 950 (S:H 1:9), 736 (S:H 1:19), 553 (S:H 1:49), 427 (S:H 1:99), 328 (S:H 1:399), 295 (S:H 
1:999). 
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organized differently from that of prokaryotic cells. Eukaryotic genetic material is organized as a 
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possess a unique circular chromosome and, in some cases, extrachromosomal replicons known as 
plasmids, which, for several bacteria such as Shigella species (spp.), are relevant for their virulence 
[25]. The RNA content of eukaryotic and prokaryotic organisms is typically about two orders of 
magnitude different, with about 20 pg and 0.1 pg of total RNA per eukaryotic and prokaryotic cell, 
respectively [26]. When considering their average sizes, the protein content of eukaryotic and 
prokaryotic organisms differs typically over ~1000 fold (i.e., 300 pg and 0.2 pg in case of a HeLa and 
Escherichia coli cell, respectively) [18] (Figure 1). More specifically, when considering the number of 
protein molecules per individual cell, a HeLa cell has been reported to contain 1010 proteins and an 
E. coli cell 3 × 106 proteins, thus about 3000 times more proteins molecules [27]. With estimated 
volumes of 3000 µm3 and 1 µm3 in case of a human and E. coli cell, respectively, this difference is 
Figure 2. Heat map representation of identified Salmonella proteins and corresponding label-free
quantification (LFQ) intensities when analyzin complex host/p th ge peptide mixtures. Complex
peptide mixtures obtain d from a tryps dig ted total Salmonella protein lys te (S) dilution series
(as indicated in the Figure) in protein lysates of hu an HeLa cells (H) were analyzed by liquid
chromatography coupled with tandem mass spectrometry (LC-MS/MS) and the protein abundance
quantified using label-free quantification (LFQ) [24]. In the heat map, the red and green color indicates
high and low LFQ intensities (log2 (LFQ)) as shown by the color scale bar in log2 LFQ), respectively and
white indicates that the protein was not identified in the corresponding experimental setup analyzed.
In the upper part of the figure, the bar chart shows the number of proteins identified in every condition.
The precise number of Salmonella proteins identified was 1600 (S), 1391 (S:H 1:1), 1120 (S:H 1:3), 950
(S:H 1:9), 736 (S:H 1:19), 553 (S:H 1:49), 427 (S:H 1:99), 328 (S:H 1:399), 295 (S:H 1:999).
Besides the increased genome compl xity of most eukary tes, the DNA of euk ryotic cells is
also organiz d differently from that f prokaryotic cells. Eukaryotic genetic material is organized as a
macromolecular structure of highly packed DNA and proteins known as chromatin. Bacteria usually
possess a unique circular chromosome and, in some cases, extrachromosomal replicons known as
plasmids, which, for several bacteria such as Shigella species (spp.), are relevant for their virulence [25].
The RNA content of eukaryotic and prokaryotic organisms is typically about two orders of magnitude
different, with about 20 pg and 0.1 pg of total RNA per ukaryotic and prokaryot c cell, respectively [26].
When considering their average sizes, the protein content of eukaryotic a d prokaryotic organisms
differs typically over ~1000 fold (i.e., 300 pg and 0.2 pg in case of a HeLa and Escherichia coli cell,
respectively) [18] (Figure 1). More specifically, when considering the number of protein molecules per
individual cell, a HeLa cell has been reported to contain 1010 proteins and an E. coli cell 3× 106 proteins,
thus about 3000 times more proteins molecules [27]. With estimated volumes of 3000 µm3 and 1 µm3
in case of a human and E. coli cell, respectively, this difference is largely explained by the increase in
the volume and not to an increase of protein mass per unit volume. More specifically, the protein mass
per unit volume was calculated to be 2.7 × 106 proteins/µm3 and 3.5 × 106 proteins/µm3, for HeLa
and E. coli cells, respectively. Altogether, this highlights that when applying omics to understand
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pathogenic processes involved in host–pathogen interactions, these substantial differences in molecular
content cannot be neglected.
Another level of complexity is imposed by the heterogeneity among infected cells, and further,
not all cells will be infected in a cell culture. More specifically, the number of bacteria per infected cell
and stage of infection can (greatly) vary among infected cells (Table S1). As such, when setting up an
infection model, several considerations have to be made. Some of these are the multiplicity of infection
(MOI) and internalization conditions in the case of intracellular bacteria, host cell-type dependency of
intracellular pathogen replication in infected cells, and viability of the infected cells and of the bacteria.
Illustrative of this, upon infection of the host, Salmonella spp. colonize the gut, where it promotes its
own internalization in epithelial cells [28]. After passing through the epithelial barrier, S. typhimurium
can be phagocytized by macrophages and dendritic cells (DCs), explaining the widespread use of
epithelial, macrophage and dendritic cell lines next to primary cell cultures (Table S1). Since a bacterial
pathogen typically targets only (a) particular cell type(s) during infection, it is thus extremely important
to carefully consider which representative infection model to use. As illustrated in Table S1, in the
case of Francisella tularensis, many studies used myeloid primary cells or cell lines since these are the
primary target cells and replicative niche of this bacterial pathogen. Many other different cell lines can
be used as host models such as epithelial cell lines (HeLa or Caco-2), phagocytic cell lines (J774A.1
murine macrophages, THP-1 human monocytes) or primary cells such as monocyte, bone marrow
derived macrophages or dendritic cells from human or murine origin, as well as neutrophils.
Most studies on intracellular pathogens use antibiotics to kill extracellular bacteria following
their addition to host cell cultures enabling the focus on internalized bacteria. Generally, host cells
are first seeded after which bacteria are added to the culture medium, which is followed by an
incubation with the host cells for a given period (typically ranging from 30 to 60 min) to allow bacterial
internalization. Then, non-internalized bacteria are washed out, and antibiotics are added to ensure
killing of extracellular bacteria that adhered to the cells but were not internalized. This procedure
is referred to as an antibiotic protection assay and most commonly the antibiotic gentamicin is
used. With short incubation times, gentamicin does not enter host cells, hence it does not affect
intracellular bacteria [29]. Following an antibiotic protection assay, intracellular bacteria are quantified
by colony forming unit (CFU) enumeration or, alternatively, the number of infected cells can be
estimated following fluorescence microscopy or using flow cytometry. Using microscopy, the number
and the distribution or location of bacteria within host cells or cell-associated bacteria can be
determined in a quantitative manner as, for example, shown by Malik-Kale et al. [30] who made
use of mCherry expressing Salmonella. By measuring mean fluorescence intensities, flow cytometry
enables semi-quantitative analyses as demonstrated by Raybourne et al. [31] who compared the
intracellular L. monocytogenes content of human monocytes and granulocytes by pre-labeling bacteria
with a lipophilic fluorescent dye. Isolation of infected cells using fluorescence-activated cell sorting
(FACS) typically relies on the exogenous expression of fluorescent proteins, like green fluorescent
protein (GFP), by pathogens [32–35]. Not surprisingly, several of these techniques are often used in
parallel to answer complex biological questions. Moreover, it is important to highlight that expression
of exogenous fluorescent proteins from plasmids can affect the virulence of Salmonella spp. [36].
Evidence for this was provided by Clark et al. [37] who observed a reduction in the expression
of Salmonella pathogenic island 1 (SPI-1) genes and a reduced infectivity of bacteria containing a
GFP-expressing plasmid or empty control plasmid. On the other hand, to avoid the expression of GFP
protein from plasmids, the gfp gene can be directly cloned in the bacterial chromosome allowing for its
expression from a constitutive promoter [38].
Another important parameter to consider is the multiplicity of infection (MOI), in bacteriology
defined as the ratio of bacteria to eukaryotic host cell. This parameter should be newly established for
different pathogens in relation to their hosts and their cellular states. For instance, when Y. pestis is
used to infect macrophages, the latter may undergo apoptosis [39], which shows the importance of
the appropriate MOI selection dependent of the research question. However, often it is not easy
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to find a consensus MOI between different studies (Table S1) as, for example, L. monocytogenes
internalization was shown to be significantly different when comparing MOIs of 1 and 10 amongst
different studies [40]. Furthermore, using the same approach, it was reported that the percentage of
infected cells at 4 and 24 hpi depends on the MOI used to infect cells [38]. The authors reported that
more than 75% of HeLa cells infected with S. typhimurium are infected at 4 hpi when an MOI of 100 is
used, whereas an MOI of 10 only resulted in 5% of the cells being infected. As such, caution is needed
when extrapolating the results from different studies. Generally, increasing the MOI will increase the
percentage of infected cells, as shown when infecting endothelial cells with Staphylococcus aureus [41]
or when infecting macrophages with Mycobacterium smegmatis [42]. At a certain MOI, the percentage
of infected cells stops increasing and it reaches a plateau [43]. The first MOI that allows reaching this
plateau is defined as the optimal MOI (as many infected cells as possible). As described for Yersinia spp.,
cell viability should also be considered when defining MOI values. Therefore, a compromise must
be made between an optimal MOI to obtain sufficiently high number of infected cells and one that
will not compromise the viability of cells. Dependent on the research question, appropriate MOIs
typically range from 5 to 100 (Table S1). Of note, even at an optimal MOI, not all cells will be infected;
Jantsch et al. [44] reported that, upon infection of bone marrow derived DCs (BMDCs)—in which
Salmonella spp. are not replicative—only 40% of the BMDCs were infected as determined by flow
cytometry. The absence of replication in these cells makes omics studies more challenging given the
limited amount of pathogenic material available. Interestingly, however, this model resembles the
early time points of Salmonella spp. infection in the case of macrophages and epithelial cells when
bacteria are not yet replicative. In another study performed in HeLa cells using the same Salmonella
strain [30], the number of intracellular bacteria was found to differ among infected cells throughout
time. Using mCherry-labeled bacteria, the number of intracellular replicative Salmonella bacteria was
counted by fluorescence microscopy and it was found that 2 hpi, infected cells contained about 20
bacteria, whereas at 8 and 16 hpi this number ranged between 20 and 100. Overall, these examples
clearly illustrate that not all cells become infected and, and when considering infected cells, the number
of intracellular bacteria per cell can vary greatly.
Finally, the growth phase and composition of the media used during in vitro infections must
be considered. For example, when studying Salmonella spp. invasion of epithelial cell lines, the late
exponential phase was shown to be the phase during which Salmonella pathogenesis island-1 (SPI-1) is
highly induced, and therefore the more suitable growth phase for infection [45]. Many studies make
use of opsonizing antibodies or proteins of the complement system present in serum when phagocytic
cells are used [46]. Opsonization is carried out to ensure bacterial internalization into phagocytic
cells by phagocytosis, a key process for host defense during infection [47]. In case of F. tularensis
infecting bone marrow derived macrophages, opsonized bacteria are more efficiently phagocytized
than non-opsonized bacteria as shown by Geier et al. [48]. Moreover, when studying the Gram-positive
pathogen L. monocytogenes, Kolb-Maurer et al. [49] showed that, upon replacing fetal calf serum
(FCS) in the culture medium by human plasma, the bacteria were more actively taken up by the cells
(Table S1). Additionally, when Salmonella was used to infect bone marrow derived macrophages [50],
opsonization with mouse whole serum was performed prior to infection. It is also important to
consider that the switch from bacterial to host cell growth media when performing the infection might
introduce (substantial) changes in the gene expression profile of bacteria, necessitating the need for the
inclusion of appropriate controls. Moreover, despite considering the intrinsic limitations when isolating
samples for omics studies, it is important to consider a wide variety of experimental parameters when
comparing the outcome of host pathogen interaction studies. We found data comparison to be
complicated viewing the lack of essential information provided next to the diversity of technologies
and instruments used and the wide variety of differing parameters among the experimental setups
studied. More specifically, information on the MOI used, CFU recovered, bacterial growth phase,
culture conditions of the host cells, infection conditions, time-points and sensitivity of instrument used
to acquire the data is often lacking.
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3. Transcriptome Analyses during Infection to Study Gene Expression Profiles of Host and
Pathogen Simultaneously: RNA-Seq Supplanting Microarrays
Transcriptomics refers to the study of an organism’s transcriptome, which is the totality of its RNA
transcripts. Hence, transcriptomics allows detection of the expressed gene pool. Transcriptomes have
classically been studied using DNA microarrays [51]. Briefly, RNA is extracted from the cells, converted
to cDNA via reverse transcription, fluorescently labeled by PCR amplification [52] and hybridized
with immobilized gene-specific DNA probes. Upon hybridization, the fluorescence signals allow
detecting the transcripts and quantification of their levels. Moreover, by using different fluorescent
labels, multiple transcriptomes can be studied simultaneously [53]. Even though microarrays allowed
the study of pathogen transcriptomes in infection models [54], with the advent of next-generation
sequencing approaches enabling high-throughput sequencing, massively parallel cDNA sequencing
or RNA-seq quickly took over. An extensive overview of RNA-seq approaches together with their
technical advantages over microarray techniques has recently been reviewed [55,56].
RNA-seq holds some interesting advantages over microarrays that are important when studying
host–pathogen interactions. More specifically, RNA-seq has a broader dynamic range than microarrays
(105 and 103, respectively [57]), allowing for addressing larger fold-changes in gene expression.
RNA-seq also enables detection of low abundance transcripts and allows discriminating between
different transcript isoforms and identification of genetic variants. Important for host–pathogen studies
and due to its high sensitivity [58], simultaneous gene expression profiling of both pathogen and host
became possible. Moreover, as RNA-seq is sequencing-based and read mapping onto the respective
genomes is performed in silico, cross-reactivity when studying different species, an important
drawback of microarrays, does not any longer occur. More specifically, in recent years, several studies
made use of dual RNA-seq, a term coined by Westermann et al. [56], when studying host–pathogen
interactions using in vitro and ex vivo infection models (reviewed in [26]). When assuming 10 bacteria
per infected cell, sequencing depth requirements to obtain correct reflections of both host and pathogen
expression profiles were estimated to be 200 and 2000 million total reads for rRNA depleted and
total RNA samples, respectively [56]. Of note, however, while these sequencing depths suffice to
determine changes in gene expression, sequence coverage of the transcriptomes obtained this way is
still too low to provide detailed information regarding transcript structure, delineation of transcript
boundaries, etc. Using dual RNA-seq, some of the studied pathogens include S. typhimurium [38],
S. aureus [59], uropathogenic E. coli (UPEC) [60], Chlamydia trachomatis [61], Mycobacterium bovis [62] and
Haemophilus influenzae [63]. More recently, dual RNA-seq was also used to simultaneously study host
and pathogen gene expression profiles using in vivo infection models (reviewed in [26]). Briefly, gene
expression was analyzed in mice infected with Pseudomonas aeruginosa, after lung tissue resection [64].
In another study, Peyer’s patches from mice infected with Yersinia pseudotuberculosis were analyzed [65].
In both cases, infected tissues were isolated and homogenized prior to total RNA extraction for
sequencing. Since multiple types of cells might be involved, this approach has also been generally
referred to as multi RNA-seq [26].
While both in vitro [38] and in vivo approaches ideally require a priori isolation of infected
cells and even though in vivo models of host–pathogen interactions represent optimal conditions to
understand bacterial pathogenesis, the composite gene expression profiles originating from a variety
of host cell types observed in the case of the latter complicate data interpretation even further and thus
optimally require separation of the different types of infected cells. Moreover, increased heterogeneity
in bacterial pathogen populations might add another level of complexity to multi RNA-seq studies,
making it, for example, also necessary to differentiate between the intra- or extracellular origin of
bacteria without a priori isolation of infected cells as for instance, Salmonella alternates between a
proliferative intracellular stage and an extracellular disseminative stage [66]. Since efficient and
cost-effective separation methods are still lacking, the use of multi RNA-seq to study host–pathogen
interactions remains somewhat limited [26].
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4. Proteomics of Bacterial Pathogens in the Context of the Host—Overcoming the Overwhelming
Host Proteome Contribution
To obtain sufficient quantities of a pathogen’s proteome from the infected host, enrichment and
isolation protocols have been devised. Overall, the main objective of these is to reduce the contribution
of host proteins to the isolated bacterial proteome content, thereby increasing the overall sensitivity
of mass spectrometry (MS) based detection of bacterial proteins. Intact bacteria can be isolated from
lysates of infected host cells using different methods such as differential centrifugation, fluorescence
activated cell sorting (FACS) based cell sorting and immune (magnetic) selection, all of which rely on
intrinsic or acquired properties that enable their selection. Next to these strategies, various approaches
have been reported that enable specific bacterial protein labeling with non-natural amino acids and
subsequent enrichment of labeled proteins.
4.1. Physical Separation Based Approaches for Isolating Intact Bacterial Pathogens upon Infection
Centrifugation-based approaches make use of infected host cells that are lysed by specific
detergents. Triton-X100 is typically used as it enables selective lysis of the membranes from eukaryotic
cells, leaving the membranes of bacterial cells intact. Thus, detergent-based lysis of infected host cells
allows the isolation of intact and viable bacteria upon centrifugation. Using differential centrifugation,
Yanhua Liu and coworkers studied the proteome of intracellular Salmonella infected HeLa cells [67].
The authors recovered a large amount of bacteria (i.e., ~108 bacteria). After MS analysis, 1675
Salmonella proteins and 251 host contaminants proteins (i.e., about 13% of all proteins identified)
were identified on average. Differential centrifugation was also used to study the proteome of several
bacterial pathogens in both in vitro and in vivo infection models. Examples include Shigella [68,69],
Listeria [70–72], Yersinia [73] and Brucella [74] spp.
Upon internalization, certain pathogens end up in specific subcellular vacuoles; so-called
bacteria containing vacuoles (BCVs) (i.e., Salmonella, Legionella, Shigella, Mycobacterium, Yersinia and
Francisella spp.). Pathogens inside BCVs can manipulate host cells’ pathways by interacting with
particular targets through secretion of effector molecules. For instance, Salmonella induces its own
engulfment in epithelial cells and is found in a membrane-bound compartment, known as the
Salmonella-containing vacuole (SCV). This compartment is specially adapted by the bacteria to allow
its own survival and replication [75]. By means of subcellular fractionation of infected cells using
sucrose-density centrifugation, SCVs can be fairly purely isolated with subsequent recovery of viable
bacteria. In the work of Santos et al. [76], the authors report a recovery of about 30 million bacterial
cells when infecting 60 million HeLa cells at an MOI of 100. Inclusion of an immunoprecipitation
(IP) step, such as the SseF IP performed in [77] and targeting a Salmonella secreted effector residing
in the SCV membrane, might also be considered as a bacterial enrichment method as it yields purer
SCV fractions. However, viewing the losses associated with such a workflow, the input material
required is high and the sample manipulations costly and labor intensive making it not very suitable
for downstream proteomics analysis [77]. Finally, in the particular case of Salmonella spp., which can
survive and replicate in the cytosol of infected epithelial cells [30,78], a drawback of this approach is
that it only enriches the bacterial population inside SCVs, thus neglecting the (possible) contribution
of cytosolic bacteria to the overall infection process.
Using FACS based isolation, Becker and coworkers purified GFP expressing Salmonella from
ex vivo infected mouse spleen and caecum cells [79]. In their study, 370 Salmonella proteins could
be identified from spleen isolates and 835 proteins from caecum. Nevertheless, host contaminants
were frequently observed in both samples as from all identified proteins in the spleen and caecum
samples 70% and 25% originated from host proteins, respectively.
Another strategy uses immune (magnetic) selection (I(M)S) of bacteria. Again, this strategy relies
on the isolation of the microorganisms after selective lysis of host cells by detergents, followed by
the use of specific antibodies raised against a particular microorganism [80]. These antibodies are
obtained by immunization of animals and collection of antisera against accessible epitopes presented
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by the pathogen. Twine et al. used I(M)S [80] to isolate Francisella bacteria. In their study, spleen
homogenates from infected mice were incubated with magnetic beads coupled with anti-Francisella
rabbit sera, which allowed for the isolation of up to ~49% of all bacteria (80 million bacterial cells)
present in the spleen homogenate [80].
Even though physical isolation-based methods, such as FACS and I(M)S, allow separating bacteria
from the host upon infection, their application is biased and restricted by several aspects, such as the
ability to genetically manipulate the microorganisms, the capacity to obtain specific antibodies and the
amount of sample needed. For instance, genetic manipulation of the Gram-positive pathogen S. aureus
to express fluorescent proteins cannot be easily achieved [81]. Moreover, the scarce availability of
antibodies targeting specific pathogens limits the wide applicability of immunoselection. An alternative
approach is based on labeling bacteria with gold (Au) or ferric oxide-core (FeOx) poly (vinyl alcohol)
coated fluorescence-labeled nanoparticles (NP) [82]. These NPs are internalized by S. aureus prior to
infection and allow their subsequent isolation by FACS or magnetic separation. It is noteworthy
however, that NP engulfment has been shown to affect the normal growth of the bacteria as a
longer lag phase was observed due to bacterial adaptation to the NPs. To further characterize
this, the authors used quantitative proteome analysis to analyze the protein expression profile of
bacteria upon incubation with or without NPs. Several proteins with different expression profiles were
observed this way. Moreover, upregulation of proteins involved in the anti-oxidative stress response
indicates that S. aureus is exposed to mild oxidative stress when grown in the presence of FeOx-NP.
To conclude, all of these strategies are powerful methods and have been successfully applied to study
host–pathogen interactions. Nevertheless, as reported in several studies, optimization is still needed to
increase the purity of the bacterial proteins obtained.
4.2. Protein Labeling-Based Isolation of the Bacterial Proteome in Infection Models
In cellulo, labeling of bacterial proteomes is typically achieved using non-natural amino acids
that are exclusively incorporated into the bacterial but not the eukaryotic proteome (Figure 3A). Given
that selective labeling of bacterial proteins occurs before lysis of infected cells, such approaches do not
require a priori physical separation of bacteria from host cells in contrast to the strategies described
above [83,84]. For a comprehensive review of labeling approaches, we refer to Tirrell et al. [85].
Typically, functional groups of non-natural amino acids incorporated into bacterial proteins by
the translation machinery enable specific derivatization of labeled proteins and their subsequent
isolation [85]. Some of the non-natural amino acids used, such as the azide-bearing methionine
surrogate azido homoalanine (AHA), can be loaded to methionyl-tRNA following wild-type
aminoacyl-tRNA synthetase (aaRS) activation of AHA. Unlike AHA, however, trans-crotylglycine (Tcg)
or azido norleucine (ANL), other methionine surrogates, are not activated (efficiently) by wild-type
aminoacyl-tRNA synthetases and respectively require overexpression of methionyl-tRNA synthetase,
or the expression of a mutant aaRS [85], enabling the (nearly) exclusive incorporation in bacterial
proteins. One area of research where these approaches have been applied is the selective isolation
and identification of the newly synthesized proteome [86,87]. More specifically, when AHA is
added to the media for a (short) pulse, it will first be incorporated into newly synthesized proteins,
an approach referred to as biorthogonal noncanonical amino acid tagging (BONCAT) [86]. Since
AHA contains a biorthogonal azido group, a chemical group that does not interfere with native
biochemical processes nor has any biological activity, upon extraction of the total proteome content,
specific labeling of proteins containing AHA can be obtained by azide–alkyne cycloaddition also
known as click chemistry [88]. Here, the alkyne group can be conjugated to different molecules, like
fluorophores or biotin, which allows fluorescent based inspection (e.g., microscopy) or isolation by
affinity purification respectively. Nevertheless, when studying host–pathogen interactions, labeling
with AHA is not applicable because both the pathogen and host proteomes may incorporate this
surrogate, as explained above.
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A way to overcome this issue came with the discovery of variants of aaRS that can activate specific
non-natural amino acids [89] since such aaRS mutants can be selectively expressed in bacteria but not
in the host, which allows for selective labeling of bacterial proteomes in the context of the infected
host [83,84]. More specifically, Ngo et al. [83] used an E. coli strain constitutively expressing mutant
methionyl-tRNA synthetase (i.e., NLL-MetRS) [89] to infect macrophages in medium supplemented
with ANL. After lysis of the infected cells, proteins were clicked with alkyne-functionalized biotin.
Biotin-clicked bacterial proteins were subsequently enriched by streptavidin-aided affinity purification.
In another study, Grammel and coworkers [84] ectopically expressed E. coli NLL-MetRS in Salmonella,
which also enabled ANL incorporation into Salmonella proteins. Additionally, the authors used
the alkynyl isostere of ANL, 2-amino-octynoic (AOA) instead of ANL [84], and showed that, in
their experimental conditions, AOA resulted in a lower background signal typically resulting from
non-specific cross-reactions. In this study, different AOA pulses were used to study the alteration of
the Salmonella proteome in infected macrophages. Despite the fact that 85% of all protein identifications
originated from Salmonella, only 195 Salmonella proteins were identified [84]. Even though biorthogonal
labelling represents an alternative approach to avoid physical isolation methods, its implementation
has the limitation that only proteins containing methionines will be (partially) labelled. In the case
of Salmonella, 96% of its proteome contains one or more Met residues in addition to the N-terminal
initiator Met residue. Moreover, the incorporation of non-natural amino acids into the proteins can
have a metabolic effect as shown for the intracellular parasite Toxoplasma gondii [90], and therefore
might affect the infection process.
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Figure 3. Bio-orthogonal labeling and purification of labeled bacterial (secreted) proteins from infected
host cells. The scheme depicts the workflow for bio-orthogonal tagging of bacterial proteins with
non-natural amino acids followed by click chemistry, and isolation of labeled pathogen proteins. Host
cells are infected with bacteria, non-natural amino acids are added to the medium prior to infection
(pre-labeled bacteria), or upon infection. Bacteria expressing the mutant methionyl-tRNA synthetase
(NLL-MetRS), can incorporate non-natural Met analogous exclusively into bacterial proteins. Newly
synthetized bacterial proteins will thus incorporate this non-natural Met. After infection, host cells are
lysed either in (A) a selective manner keeping bacterial cells intact (e.g., to study the bacterial secretome)
or (B) by complete lysis enabling to study the proteome of the pathogen and host simultaneously during
infection in a more global manner. Particularly, in the case of (A), bacterial cells are typically removed
by centrifugation before downstream processing of the obtained lysate. Subsequently, proteins are
clicked using alkyl-biotin (blue). In this step, only proteins that have incorporated non-natural amino
acid will be conjugated to biotin. Finally, a purification step using streptavidin affinity chromatography
is performed. Here, non-tagged proteins do not bind the streptavidin resin and are thus easily removed,
while the biotinylated (clicked) proteins can be recovered. Thus, bacterial (secreted) proteins are highly
enriched in the sample and can be studied to understand changes in the secretome (A) or in the bacterial
proteome (B) of a bacterial pathogen during infection.
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5. Secretomics for Identifying Bacterial Extracellular Effectors Involved in Infection
The term bacterial secretome was coined in studies of the eubacteria Bacillus subtilis by Tjalsma et al.
in 2000 [91] and Antelmann et al. in 2001 [92]. It was initially used to refer to both the secreted proteins
and the actual secretion machinery. However, the current paradigm in the field has shifted to define the
secretome in a broader way as not only the subset of secreted proteins or so-called exoproteome [93],
but also including bacterial proteins that interact with the extracellular environment such as the
membrane-anchored adhesins which facilitate adherence to the surface or to host cells [94]. These
proteins are part of the cell wall proteome and some of them have key roles in virulence, such as in the
evasion of the host immune response [71].
Bacterial secretomes have been studied by different approaches including in silico identification
of secretion signals, isolation of the secretomes of in vitro cultured microorganisms under different
growth conditions and screening of proteins by phage display. In silico based approaches rely on
algorithms to find consensus secretion signals characteristic of secreted proteins [95]. Secreted proteins
are usually targeted to the secretory pathway by a signal either encoded in the N-terminal region of
the protein or by the 5′ end of the mRNA sequence [96]. While in silico secretome predictions enable
the rapid discovery of potential secreted proteins, empiric validation of candidates is required to show
that these proteins indeed belong to the secretome. Such validation is not always straightforward,
amongst others because proteins predicted to be secreted might be poorly expressed. Furthermore,
this approach relies on proper genome annotation, which is not always available. In addition, in vitro
techniques typically identify secreted proteins in culture supernatants after physical separation from
the bacteria [97–102]. Particularly, this approach has been used to study secretomes of several species
of the Gram-positive human pathogen Streptococcus under different growth conditions [103,104].
This way, more than 100 secreted proteins could be identified in each case. However, in such studies,
bacteria are grown in conditions that only mimic the host environment. Hence, the actual set of
proteins secreted upon interaction with the host might be different from the protein set obtained
in vitro. Phage display is based on the generation of a library containing up to 1012 phage particles
displaying different bacterial protein(s) (parts) [105]. This strategy for studying the secretome can
be used when proteins interacting with host cells, the extracellular matrix, serum proteins such as
antibodies and the complement system are used as baits to fish out those bacterial proteins that
are potentially secreted or membrane associated [106]. Therefore, the use of phage display for the
identification of secretome proteins is limited to those proteins interacting with host surfaces (reviewed
by Gagic et al. [105]), thus missing the intracellular host targets of secreted proteins.
Recently, however, enrichment of bacterial secretomes using in vitro infection models was
reported [107,108]. Both studies used biorthogonal labeling of bacterial proteins with ANL to isolate
the secretome (Figure 3B). Mahdavi and coworkers [107] studied the secretome of Yersinia enterocolitica
infected HeLa cells. In this work, effectors secreted by extracellular or intracellular Yersinia were
identified. At the early stage of infection, Yersinia is extracellular and uses a type III secretion
system (T3SS) to inject effectors into the host. Interestingly, infection can be detected due to the
changed morphology of HeLa cells after injection of the effectors. In their experimental setup, Yersinia
constitutively expressing NLL-MetRS was used to infect HeLa cells in media supplemented with ANL.
Upon selective lysis of the host and removal of intact bacteria, effectors injected in host cells were
enriched and subsequently identified by mass spectrometry. A similar strategy, but now including
a step to eliminate extracellular bacteria by a gentamicin protection assay, was performed in [29].
This way, upon lysis of the host cells, protein secreted by intracellular bacteria could be identified. The
outcome of these two strategies, was the identification of two different groups of secreted proteins;
namely eight T3SS-effectors (three secreted by extracellular Yersinia and five by intracellular Yersinia)
and five secreted effectors not secreted by T3SS as demonstrated when making use of a mutant strain
deficient in type III secretion. Finally, pulses with ANL allowed for a time-lapse study of the secreted
effectors during the process of Yersinia infection and the order of the different injected proteins could be
established. Another study carried out by Chande and coworkers [108] also used ANL incorporation
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into mycobacterial proteins to identify secreted effectors by different virulent Mycobacterium strains
infecting THP-1 monocytes at different time points. Here, a Mycobacterium codon-adapted NLL-MetRS
was used and the bacteria labeled 12 h prior to infection. Presumably, pre-labeling is required due to the
slow growth rate of Mycobacterium [109]. By using label-free proteomics, the authors could identify 15
to 30 secreted proteins in three different strains, and quantified differences in their abundance at
different time points. Of note, the time points performed in this study differed 12 h in time, while the
time points of Yersinia study described above were collected 30 min apart [107], again highly likely in
line with the different growth rates exhibited by these pathogens.
6. Ribosome Profiling as the Next Big Step of Future Endeavors for Studying Bacterial
Translatomes upon Host Cell Infection?
Despite the recent advances made in studying bacterial protein synthesis by means of proteomics,
both the difficulty of distinguishing newly translated and nascent proteins from the pre-existing
protein pools (e.g., when identifying newly translated bacterial proteins upon infection) next to the
increasing capabilities of NGS in terms of throughput and sensitivity, spurred an awareness to start
analyzing bacterial protein translation at the level of the transcriptome/genome.
Only recently, ribosome profiling (or Ribo-seq) revolutionized the study of translation by
deep sequencing of ribosome-protected mRNA fragments [110], thereby expanding our current
understanding of the genomic architecture and coding potential for a wide variety of organisms
to an unprecedented extent [111]. Moreover, recent ribosome profiling studies performed by us and
others enabled translatome studies of bacterial cells, not only revealing translation of numerous
previously unidentified (small) open reading frames, so-called pseudogenes and translation from
numerous alternative translation initiation events including near-cognate start sites [112–115], but also
empowering differential gene expression studies under infection relevant conditions [116].
Unlike the multitude of viral translation studies reported in the context of infection [117],
and likely complicated due to the significant differences between bacterial and eukaryotic translation,
to date, no bacterial translatome-oriented studies in the context of infection have been reported.
Interestingly, however, unlike strategies relying on physical methods to separate cell types and
cell enrichment strategies, genetically encoded systems were reported studying mRNA translation
in different cell (sub-) populations [118,119]. More specifically, by expressing an epitope tagged
ribosomal protein in a cell-dependent manner or under a tissue-specific promotor, translating ribosome
affinity purification (TRAP) and RiboTag approaches enabled tissue or cell-type specific profiling
of translatomes by the selective recovery (i.e., immunopurification) of tagged polysome-associated
mRNAs from cells expressing a tagged ribosomal subunit [120,121].
In principle, similar strategies making use of ribosome tagged bacterial strains [122] would
permit selective isolation of bacterial ribosomes when studying the bacterial translatome in a host cell
specific context. Moreover, as in the case of the multi RNA-seq strategies described above, it is still
highly preferable to enrich for the desired subset of bacterial transcripts, especially in the context of
newly translated proteins. Again, in silico discrimination between host and pathogen can simply be
performed by mapping the data onto respective reference genomes.
7. Conclusions
The implementation of proteogenomics approaches for the study of host pathogen interactions
encounters its major limitation in the discriminative power required to study pathogen and host
simultaneously throughout the infection process. To try to overcome these limitations, several
approaches in the fields of transcriptomics and proteomics have recently emerged, permitting host as
well as pathogen focused proteome and transcriptome studies. Importantly, since for most bacterial
pathogens, the complete repertoire of effectors employed to establish a successful infection remains
unknown, by performing integrative analysis of gene and protein expression data, a more qualitative
and refined set of true protein coding potential of the pathogen in its host context can be envisaged.
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Furthermore, by providing an unprecedented understanding of interactions between pathogen and
host, the identification of potentially new pathogen virulence factors will be facilitated.
Supplementary Materials: The following material is available online www.mdpi.com/2227-7382/5/4/26/s1,
Table S1: Models used for studying host-pathogen interactions.
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